Select your language

Other official information and services: www.belgium.be  belgium

  • Key figures
  •  Data
  • Graphics
  • Comments
PRESCRIBERS
Main prescribers: General practitioners 79.06%
INSURED CONSUMERS
% of insured consumers 41.81%
Median age 76 years
Max/min ratio of the median age (by district) 1.04
Percentage of women 54.93%
Ratio Preferential scheme/General scheme 1.32
Coefficient of variation (2022) 8.13
Max/min ratio of % of insured consumers (by district) 1.36
CONSUMPTION
Annual consumption (DDD) 2,062,854,905
Consumption of DDD (per 100,000 insured persons) 85,991,736.40
% DDD issued outside the insurance (approximate) 31.74%
Average annual consumption per insured consumer (DDD) 2,056.54
% of insured consumers with > 3 times the average consumption 0,39%
Coefficient of variation (% of insured consumers) 2019-2021 9.35
Coefficient of variation (% of insured consumers) 2020-2022 9.36
Trend 2019-2022 0.44%
Trend 2019-2019 NA
Trend 2019-2022 0.44%
DIRECT EXPENDITURE (DDD)
Annual expenditure charged to the insurance 880,661,706
Average annual expenditure per insured person 367.11
Average patient share per insured consumer 11.98%
Max/min ratio of expenditure per insured person (by disctrict) 1.45
% “Low-cost” medication 68.92%
Trend 2019-2022 3.45%
Trend 2019-2022 3.45%


On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.

CODES (ATC-5) LABELS
A01AA CARIES PROPHYLACTIC AGENTS
A01AB ANTIINFECTIVES AND ANTISEPTICS FOR LOCAL ORAL TREATMENT
A01AC CORTICOSTEROIDS FOR LOCAL ORAL TREATMENT
A01AD OTHER AGENTS FOR LOCAL ORAL TREATMENT
A02AB ALUMINIUM COMPOUNDS
A02AC CALCIUM COMPOUNDS
A02AD COMBINATIONS AND COMPLEXES OF ALUMINIUM, CALCIUM AND MAGNESIUM COMPOUNDS
A02AF ANTACIDS WITH ANTIFLATULENTS
A02AG ANTACIDS WITH ANTISPASMODICS
A02AH ANTACIDS WITH SODIUM BICARBONATE
A02AX ANTACIDS, OTHER COMBINATIONS
A02BA H2-RECEPTOR ANTAGONISTS
A02BB PROSTAGLANDINS
A02BC PROTON PUMP INHIBITORS
A02BD COMBINATIONS FOR ERADICATION OF HELICOBACTER PYLORI
A02BX OTHER DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
A02DA ANTIFLATULENTS
A03A DRUGS FOR FUNCTIONAL BOWEL DISORDERS
A03AA SYNTHETIC ANTICHOLINERGICS, ESTERS WITH TERTIARY AMINO GROUP
A03AB SYNTHETIC ANTICHOLINERGICS, QUATERNARY AMMONIUM COMPOUNDS
A03AD PAPAVERINE AND DERIVATIVES
A03AX OTHER DRUGS FOR FUNCTIONAL BOWEL DISORDERS
A03BA BELLADONNA ALKALOIDS, TERTIARY AMINES
A03BB BELLADONNA ALKALOIDS, SEMISYNTHETIC, QUATERNARY AMMONIUM COMPOUNDS
A03CA SYNTHETIC ANTICHOLINERGIC AGENTS IN COMBINATION WITH PSYCHOLEPTICS
A03CB BELLADONNA AND DERIVATIVES IN COMBINATION WITH PSYCHOLEPTICS
A03DA SYNTHETIC ANTICHOLINERGIC AGENTS IN COMBINATION WITH ANALGESICS
A03DB BELLADONNA AND DERIVATIVES IN COMBINATION WITH ANALGESICS
A03FA PROPULSIVES
A04AA SEROTONIN (5HT3) ANTAGONISTS
A04AD OTHER ANTIEMETICS
A05AA BILE ACID PREPARATIONS
A05AX OTHER DRUGS FOR BILE THERAPY
A05BA LIVER THERAPY
A06 LAXATIVES
A06AA SOFTENERS, EMOLLIENTS
A06AB CONTACT LAXATIVES
A06AC BULK PRODUCERS
A06AD OSMOTICALLY ACTING LAXATIVES
A06AG ENEMAS
A06AH PERIPHERAL OPIOID RECEPTOR ANTAGONISTS
A06AX OTHER LAXATIVES
A07AA ANTIBIOTICS
A07AB SULFONAMIDES
A07AC IMIDAZOLE DERIVATIVES
A07AX OTHER INTESTINAL ANTIINFECTIVES
A07BA CHARCOAL PREPARATIONS
A07BB BISMUTH PREPARATIONS
A07BC OTHER INTESTINAL ADSORBENTS
A07DA ANTIPROPULSIVES
A07EA CORTICOSTEROIDS ACTING LOCALLY
A07EC AMINOSALICYLIC ACID AND SIMILAR AGENTS
A07FA ANTIDIARRHEAL MICROORGANISMS
A07XA OTHER ANTIDIARRHEALS
A08AA CENTRALLY ACTING ANTIOBESITY PRODUCTS
A08AB PERIPHERALLY ACTING ANTIOBESITY PRODUCTS
A08AX OTHER ANTIOBESITY DRUGS
A09AA ENZYME PREPARATIONS
A09AC ENZYME AND ACID PREPARATIONS, COMBINATIONS
A10AB INSULINS AND ANALOGUES FOR INJECTION, FAST-ACTING
A10AC INSULINS AND ANALOGUES FOR INJECTION, INTERMEDIATE-ACTING
A10AD INSULINS AND ANALOGUES FOR INJECTION, INTERMEDIATE-ACTING COMBINED WITH FAST-ACTING
A10AE INSULINS AND ANALOGUES FOR INJECTION, LONG-ACTING
A10BA BIGUANIDES
A10BB SULFONAMIDES, UREA DERIVATIVES
A10BD COMBINATIONS OF ORAL BLOOD GLUCOSE LOWERING DRUGS
A10BF ALPHA GLUCOSIDASE INHIBITORS
A10BG THIAZOLIDINEDIONES
A10BH DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS
A10BJ GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUES
A10BK SODIUM-GLUCOSE CO-TRANSPORTER 2 (SGLT2) INHIBITORS
A10BX OTHER BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A11AA MULTIVITAMINS WITH MINERALS
A11BA MULTIVITAMINS, PLAIN
A11CA VITAMIN A, PLAIN
A11CB VITAMIN A AND D IN COMBINATION
A11CC VITAMIN D AND ANALOGUES
A11DA VITAMIN B1, PLAIN
A11DB VITAMIN B1 IN COMBINATION WITH VITAMIN B6 AND/OR VITAMIN B12
A11EA VITAMIN B-COMPLEX, PLAIN
A11EB VITAMIN B-COMPLEX WITH VITAMIN C
A11EX VITAMIN B-COMPLEX, OTHER COMBINATIONS
A11GA ASCORBIC ACID (VITAMIN C), PLAIN
A11HA OTHER PLAIN VITAMIN PREPARATIONS
A11JA COMBINATIONS OF VITAMINS
A11JC VITAMINS, OTHER COMBINATIONS
A12AA CALCIUM
A12AX CALCIUM, COMBINATIONS WITH OTHER DRUGS
A12BA POTASSIUM
A12CA SODIUM
A12CB ZINC
A12CC MAGNESIUM
A12CD FLUORIDE
A12CE SELENIUM
A12CX OTHER MINERAL PRODUCTS
A13A TONICS
A14AA ANDROSTAN DERIVATIVES
A14AB ESTREN DERIVATIVES
A16AA AMINO ACIDS AND DERIVATIVES
A16AB ENZYMES
A16AX VARIOUS ALIMENTARY TRACT AND METABOLISM PRODUCTS
B01AA VITAMIN K ANTAGONISTS
B01AB HEPARIN GROUP
B01AC PLATELET AGGREGATION INHIBITORS EXCL. HEPARIN
B01AD ENZYMES
B01AE DIRECT THROMBIN INHIBITORS
B01AF DIRECT FACTOR XA INHIBITORS
B01AX OTHER ANTITHROMBOTIC AGENTS
B02AA AMINO ACIDS
B02AB PROTEINASE INHIBITORS
B02BA VITAMIN K
B02BB FIBRINOGEN
B02BC LOCAL HEMOSTATICS
B02BD BLOOD COAGULATION FACTORS
B02BX OTHER SYSTEMIC HEMOSTATICS
B03AA IRON BIVALENT, ORAL PREPARATIONS
B03AB IRON TRIVALENT, ORAL PREPARATIONS
B03AC IRON TRIVALENT, PARENTERAL PREPARATIONS
B03AD IRON IN COMBINATION WITH FOLIC ACID
B03AE IRON IN OTHER COMBINATIONS
B03BA VITAMIN B12 (CYANOCOBALAMIN AND ANALOGUES)
B03BB FOLIC ACID AND DERIVATIVES
B03XA OTHER ANTIANEMIC PREPARATIONS
B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B05AA BLOOD SUBSTITUTES AND PLASMA PROTEIN FRACTIONS
B05BA SOLUTIONS FOR PARENTERAL NUTRITION
B05BB SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE
B05BC SOLUTIONS PRODUCING OSMOTIC DIURESIS
B05CA ANTIINFECTIVES
B05CB SALT SOLUTIONS
B05CX OTHER IRRIGATING SOLUTIONS
B05DB HYPERTONIC SOLUTIONS
B05X I.V. SOLUTION ADDITIVES
B05XA ELECTROLYTE SOLUTIONS
B05XB AMINO ACIDS
B05XC VITAMINS
B05ZB HEMOFILTRATES
B06AA ENZYMES
B06AB OTHER HEM PRODUCTS
B06AC DRUGS USED IN HEREDITARY ANGIOEDEMA
C01AA DIGITALIS GLYCOSIDES
C01BA ANTIARRHYTHMICS, CLASS IA
C01BB ANTIARRHYTHMICS, CLASS IB
C01BC ANTIARRHYTHMICS, CLASS IC
C01BD ANTIARRHYTHMICS, CLASS III
C01BG OTHER CLASS I ANTIARRHYTHMICS
C01CA ADRENERGIC AND DOPAMINERGIC AGENTS
C01CE PHOSPHODIESTERASE INHIBITORS
C01CX OTHER CARDIAC STIMULANTS
C01DA ORGANIC NITRATES
C01DX OTHER VASODILATORS USED IN CARDIAC DISEASES
C01EA PROSTAGLANDINS
C01EB OTHER CARDIAC PREPARATIONS
C02AA RAUWOLFIA ALKALOIDS
C02AB METHYLDOPA
C02AC IMIDAZOLINE RECEPTOR AGONISTS
C02CA ALPHA-ADRENORECEPTOR ANTAGONISTS
C02CC GUANIDINE DERIVATIVES
C02DA THIAZIDE DERIVATIVES
C02DB HYDRAZINOPHTHALAZINE DERIVATIVES
C02DC PYRIMIDINE DERIVATIVES
C02DD NITROFERRICYANIDE DERIVATIVES
C02DG GUANIDINE DERIVATIVES
C02KD SEROTONIN ANTAGONISTS
C02KX OTHER ANTIHYPERTENSIVES
C03AA THIAZIDES, PLAIN
C03AB THIAZIDES AND POTASSIUM IN COMBINATION
C03BA SULFONAMIDES, PLAIN
C03CA SULFONAMIDES, PLAIN
C03DA ALDOSTERONE ANTAGONISTS
C03DB OTHER POTASSIUM-SPARING AGENTS
C03EA LOW-CEILING DIURETICS AND POTASSIUM-SPARING AGENTS
C03EB HIGH-CEILING DIURETICS AND POTASSIUM-SPARING AGENTS
C03XA VASOPRESSIN ANTAGONISTS
C04AA 2-AMINO-1-PHENYLETHANOL DERIVATIVES
C04AB IMIDAZOLINE DERIVATIVES
C04AC NICOTINIC ACID AND DERIVATIVES
C04AD PURINE DERIVATIVES
C04AE ERGOT ALKALOIDS
C04AX OTHER PERIPHERAL VASODILATORS
C05AA CORTICOSTEROIDS
C05AD LOCAL ANESTHETICS
C05AE MUSCLE RELAXANTS
C05AX OTHER AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05BA HEPARINS OR HEPARINOIDS FOR TOPICAL USE
C05BB SCLEROSING AGENTS FOR LOCAL INJECTION
C05BX OTHER SCLEROSING AGENTS
C05CA BIOFLAVONOIDS
C05CX OTHER CAPILLARY STABILIZING AGENTS
C07AA BETA BLOCKING AGENTS, NON-SELECTIVE
C07AB BETA BLOCKING AGENTS, SELECTIVE
C07AG ALPHA AND BETA BLOCKING AGENTS
C07BA BETA BLOCKING AGENTS, NON-SELECTIVE, AND THIAZIDES
C07BB BETA BLOCKING AGENTS, SELECTIVE, AND THIAZIDES
C07CA BETA BLOCKING AGENTS, NON-SELECTIVE, AND OTHER DIURETICS
C07CB BETA BLOCKING AGENTS, SELECTIVE, AND OTHER DIURETICS
C07DB BETA BLOCKING AGENTS, SELECTIVE, THIAZIDES AND OTHER DIURETICS
C07FB BETA BLOCKING AGENTS, SELECTIVE, AND OTHER ANTIHYPERTENSIVES
C08CA DIHYDROPYRIDINE DERIVATIVES
C08DA PHENYLALKYLAMINE DERIVATIVES
C08DB BENZOTHIAZEPINE DERIVATIVES
C08EA PHENYLALKYLAMINE DERIVATIVES
C08EX OTHER NON-SELECTIVE CALCIUM CHANNEL BLOCKERS
C09AA ACE INHIBITORS, PLAIN
C09BA ACE INHIBITORS AND DIURETICS
C09BB ACE INHIBITORS AND CALCIUM CHANNEL BLOCKERS
C09BX ACE INHIBITORS, OTHER COMBINATIONS
C09CA ANGIOTENSIN II ANTAGONISTS, PLAIN
C09DA ANGIOTENSIN II ANTAGONISTS AND DIURETICS
C09DB ANGIOTENSIN II ANTAGONISTS AND CALCIUM CHANNEL BLOCKERS
C09DX ANGIOTENSIN II ANTAGONISTS, OTHER COMBINATIONS
C09XA RENIN-INHIBITORS
C10AA HMG COA REDUCTASE INHIBITORS
C10AB FIBRATES
C10AC BILE ACID SEQUESTRANTS
C10AD NICOTINIC ACID AND DERIVATIVES
C10AX OTHER LIPID MODIFYING AGENTS
C10BA COMBINATIONS OF VARIOUS LIPID MODIFYING AGENTS
C10BX LIPID MODIFYING AGENTS IN COMBINATION WITH OTHER DRUGS
D DERMATOLOGICALS
D01AA ANTIBIOTICS
D01AC IMIDAZOLE AND TRIAZOLE DERIVATIVES
D01AE OTHER ANTIFUNGALS FOR TOPICAL USE
D01BA ANTIFUNGALS FOR SYSTEMIC USE
D02AB ZINC PRODUCTS
D02AD LIQUID PLASTERS
D02AE CARBAMIDE PRODUCTS
D02AF SALICYLIC ACID PREPARATIONS
D02AX OTHER EMOLLIENTS AND PROTECTIVES
D03AA COD-LIVER OIL OINTMENTS
D03AX OTHER CICATRIZANTS
D03BA PROTEOLYTIC ENZYMES
D04AA ANTIHISTAMINES FOR TOPICAL USE
D04AB ANESTHETICS FOR TOPICAL USE
D04AX OTHER ANTIPRURITICS
D05AA TARS
D05AC ANTRACEN DERIVATIVES
D05AX OTHER ANTIPSORIATICS FOR TOPICAL USE
D05BA PSORALENS FOR SYSTEMIC USE
D05BB RETINOIDS FOR TREATMENT OF PSORIASIS
D06AA TETRACYCLINE AND DERIVATIVES
D06AX OTHER ANTIBIOTICS FOR TOPICAL USE
D06BA SULFONAMIDES
D06BB ANTIVIRALS
D06BX OTHER CHEMOTHERAPEUTICS
D07AA CORTICOSTEROIDS, WEAK (GROUP I)
D07AB CORTICOSTEROIDS, MODERATELY POTENT (GROUP II)
D07AC CORTICOSTEROIDS, POTENT (GROUP III)
D07AD CORTICOSTEROIDS, VERY POTENT (GROUP IV)
D07BB CORTICOSTEROIDS, MODERATELY POTENT, COMBINATIONS WITH ANTISEPTICS
D07BC CORTICOSTEROIDS, POTENT, COMBINATIONS WITH ANTISEPTICS
D07CA CORTICOSTEROIDS, WEAK, COMBINATIONS WITH ANTIBIOTICS
D07CB CORTICOSTEROIDS, MODERATELY POTENT, COMBINATIONS WITH ANTIBIOTICS
D07CC CORTICOSTEROIDS, POTENT, COMBINATIONS WITH ANTIBIOTICS
D07XA CORTICOSTEROIDS, WEAK, OTHER COMBINATIONS
D07XB CORTICOSTEROIDS, MODERATELY POTENT, OTHER COMBINATIONS
D07XC CORTICOSTEROIDS, POTENT, OTHER COMBINATIONS
D08AB ALUMINIUM AGENTS
D08AC BIGUANIDES AND AMIDINES
D08AD BORIC ACID PRODUCTS
D08AE PHENOL AND DERIVATIVES
D08AF NITROFURAN DERIVATIVES
D08AG IODINE PRODUCTS
D08AH QUINOLINE DERIVATIVES
D08AJ QUATERNARY AMMONIUM COMPOUNDS
D08AK MERCURIAL PRODUCTS
D08AL SILVER COMPOUNDS
D08AX OTHER ANTISEPTICS AND DISINFECTANTS
D09AA MEDICATED DRESSINGS WITH ANTIINFECTIVES
D09AB ZINC BANDAGES
D09AX SOFT PARAFFIN DRESSINGS
D10AD RETINOIDS FOR TOPICAL USE IN ACNE
D10AE PEROXIDES
D10AF ANTIINFECTIVES FOR TREATMENT OF ACNE
D10AX OTHER ANTI-ACNE PREPARATIONS FOR TOPICAL USE
D10BA RETINOIDS FOR TREATMENT OF ACNE
D11AC MEDICATED SHAMPOOS
D11AF WART AND ANTI-CORN PREPARATIONS
D11AH AGENTS FOR ATOPIC DERMATITIS, EXCLUDING CORTICOSTEROIDS
D11AX OTHER DERMATOLOGICALS
G01AA ANTIBIOTICS
G01AC QUINOLINE DERIVATIVES
G01AD ORGANIC ACIDS
G01AE SULFONAMIDES
G01AF IMIDAZOLE DERIVATIVES
G01AG TRIAZOLE DERIVATIVES
G01AX OTHER ANTIINFECTIVES AND ANTISEPTICS
G02AB ERGOT ALKALOIDS
G02AD PROSTAGLANDINS
G02B CONTRACEPTIVES FOR TOPICAL USE
G02BA INTRAUTERINE CONTRACEPTIVES
G02BB INTRAVAGINAL CONTRACEPTIVES
G02CA SYMPATHOMIMETICS, LABOUR REPRESSANTS
G02CB PROLACTINE INHIBITORS
G02CX OTHER GYNECOLOGICALS
G03AA PROGESTOGENS AND ESTROGENS, FIXED COMBINATIONS
G03AB PROGESTOGENS AND ESTROGENS, SEQUENTIAL PREPARATIONS
G03AC PROGESTOGENS
G03AD EMERGENCY CONTRACEPTIVES
G03BA 3-OXOANDROSTEN (4) DERIVATIVES
G03BB 5-ANDROSTANON (3) DERIVATIVES
G03CA NATURAL AND SEMISYNTHETIC ESTROGENS, PLAIN
G03CB SYNTHETIC ESTROGENS, PLAIN
G03CC ESTROGENS, COMBINATIONS WITH OTHER DRUGS
G03CX OTHER ESTROGENS
G03DA PREGNEN (4) DERIVATIVES
G03DB PREGNADIEN DERIVATIVES
G03DC ESTREN DERIVATIVES
G03EA ANDROGENS AND ESTROGENS
G03FA PROGESTOGENS AND ESTROGENS, FIXED COMBINATIONS
G03FB PROGESTOGENS AND ESTROGENS, SEQUENTIAL PREPARATIONS
G03GA GONADOTROPINS
G03GB OVULATION STIMULANTS, SYNTHETIC
G03HA ANTIANDROGENS, PLAIN
G03HB ANTIANDROGENS AND ESTROGENS
G03XA ANTIGONADOTROPINS AND SIMILAR AGENTS
G03XB ANTIPROGESTOGENS
G03XC SELECTIVE ESTROGEN RECEPTOR MODULATORS
G03XX OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
G04BA ACIDIFIERS
G04BC URINARY CONCREMENT SOLVENTS
G04BD URINARY ANTISPASMODICS
G04BE DRUGS USED IN ERECTILE DYSFUNCTION
G04BX OTHER UROLOGICALS
G04CA ALPHA-ADRENORECEPTOR ANTAGONISTS
G04CB TESTOSTERONE-5-ALPHA REDUCTASE INHIBITORS
G04CX OTHER DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
H01AA ACTH
H01AC SOMATROPIN AND SOMATROPIN AGONISTS
H01AX OTHER ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
H01BA VASOPRESSIN AND ANALOGUES
H01BB OXYTOCIN AND ANALOGUES
H01CA GONADOTROPIN-RELEASING HORMONES
H01CB ANTIGROWTH HORMONES
H01CC ANTI-GONADOTROPIN-RELEASING HORMONES
H02AA MINERALOCORTICOIDS
H02AB GLUCOCORTICOIDS
H02BX CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS
H03AA THYROID HORMONES
H03BA THIOURACILS
H03BB SULFUR-CONTAINING IMIDAZOLE DERIVATIVES
H04AA GLYCOGENOLYTIC HORMONES
H05AA PARATHYROID HORMONES AND ANALOGUES
H05BA CALCITONIN PREPARATIONS
H05BX OTHER ANTI-PARATHYROID AGENTS
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01AA TETRACYCLINES
J01BA AMPHENICOLS
J01CA PENICILLINS WITH EXTENDED SPECTRUM
J01CE BETA-LACTAMASE SENSITIVE PENICILLINS
J01CF BETA-LACTAMASE RESISTANT PENICILLINS
J01CR COMBINATIONS OF PENICILLINS, INCL. BETA-LACTAMASE INHIBITORS
J01DB FIRST-GENERATION CEPHALOSPORINS
J01DC SECOND-GENERATION CEPHALOSPORINS
J01DD THIRD-GENERATION CEPHALOSPORINS
J01DE FOURTH-GENERATION CEPHALOSPORINS
J01DF MONOBACTAMS
J01DH CARBAPENEMS
J01DI OTHER CEPHALOSPORINS
J01EA TRIMETHOPRIM AND DERIVATIVES
J01EB SHORT-ACTING SULFONAMIDES
J01EC INTERMEDIATE-ACTING SULFONAMIDES
J01ED LONG-ACTING SULFONAMIDES
J01EE COMBINATIONS OF SULFONAMIDES AND TRIMETHOPRIM, INCL. DERIVATIVES
J01FA MACROLIDES
J01FF LINCOSAMIDES
J01FG STREPTOGRAMINS
J01GA STREPTOMYCINS
J01GB OTHER AMINOGLYCOSIDES
J01MA FLUOROQUINOLONES
J01MB OTHER QUINOLONES
J01XA GLYCOPEPTIDE ANTIBACTERIALS
J01XB POLYMYXINS
J01XC STEROID ANTIBACTERIALS
J01XD IMIDAZOLE DERIVATIVES
J01XE NITROFURAN DERIVATIVES
J01XX OTHER ANTIBACTERIALS
J02AA ANTIBIOTICS
J02AB IMIDAZOLE DERIVATIVES
J02AC TRIAZOLE DERIVATIVES
J02AX OTHER ANTIMYCOTICS FOR SYSTEMIC USE
J04AB ANTIBIOTICS
J04AC HYDRAZIDES
J04AK OTHER DRUGS FOR TREATMENT OF TUBERCULOSIS
J04BA DRUGS FOR TREATMENT OF LEPRA
J05AB NUCLEOSIDES AND NUCLEOTIDES EXCL. REVERSE TRANSCRIPTASE INHIBITORS
J05AD PHOSPHONIC ACID DERIVATIVES
J05AE PROTEASE INHIBITORS
J05AF NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS
J05AG NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
J05AH NEURAMINIDASE INHIBITORS
J05AJ INTEGRASE INHIBITORS
J05AP ANTIVIRALS FOR TREATMENT OF HCV INFECTIONS
J05AR ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS
J05AX OTHER ANTIVIRALS
J06AA IMMUNE SERA
J06BA IMMUNOGLOBULINS, NORMAL HUMAN
J06BB SPECIFIC IMMUNOGLOBULINS
J06BD ANTIVIRAL MONOCLONAL ANTIBODIES
J07 VACCINES
J07AE CHOLERA VACCINES
J07AG HEMOPHILUS INFLUENZAE B VACCINES
J07AH MENINGOCOCCAL VACCINES
J07AJ PERTUSSIS VACCINES
J07AL PNEUMOCOCCAL VACCINES
J07AM TETANUS VACCINES
J07AP TYPHOID VACCINES
J07AX OTHER BACTERIAL VACCINES
J07BA ENCEPHALITIS VACCINES
J07BB INFLUENZA VACCINES
J07BC HEPATITIS VACCINES
J07BD MEASLES VACCINES
J07BE MUMPS VACCINES
J07BF POLIOMYELITIS VACCINES
J07BG RABIES VACCINES
J07BH ROTA VIRUS DIARRHEA VACCINES
J07BJ RUBELLA VACCINES
J07BK VARICELLA ZOSTER VACCINES
J07BL YELLOW FEVER VACCINES
J07BM PAPILLOMAVIRUS VACCINES
J07BN Covid-19 vaccines
J07CA BACTERIAL AND VIRAL VACCINES, COMBINED
L01AA NITROGEN MUSTARD ANALOGUES
L01AB ALKYL SULFONATES
L01AC ETHYLENE IMINES
L01AD NITROSOUREAS
L01AX OTHER ALKYLATING AGENTS
L01BA FOLIC ACID ANALOGUES
L01BB PURINE ANALOGUES
L01BC PYRIMIDINE ANALOGUES
L01CA VINCA ALKALOIDS AND ANALOGUES
L01CB PODOPHYLLOTOXIN DERIVATIVES
L01CD TAXANES
L01CE TOPOISOMERASE 1 (TOP1) INHIBITORS
L01CX OTHER PLANT ALKALOIDS AND NATURAL PRODUCTS
L01DA ACTINOMYCINES
L01DB ANTHRACYCLINES AND RELATED SUBSTANCES
L01DC OTHER CYTOTOXIC ANTIBIOTICS
L01EA BCR-ABL TYROSINE KINASE INHIBITORS
L01EB EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) TYROSINE KINASE INHIBITORS
L01EC B-RAF SERINE-THREONINE KINASE (BRAF) INHIBITORS
L01ED ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITORS
L01EE MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS
L01EF CYCLIN-DEPENDENT KINASE (CDK) INHIBITORS
L01EG MAMMALIAN TARGET OF RAPAMYCIN (MTOR) KINASE INHIBITORS
L01EH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) TYROSINE KINASE INHIBITORS
L01EJ JANUS-ASSOCIATED KINASE (JAK) INHIBITORS
L01EK VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR (VEGFR) TYROSINE KINASE INHIBITORS
L01EL BRUTON'S TYROSINE KINASE (BTK) INHIBITORS
L01EM PHOSPHATIDYLINOSITOL-3-KINASE (PI3K) INHIBITORS
L01EN FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR) TYROSINE KINASE INHIBITORS
L01EX OTHER PROTEIN KINASE INHIBITORS
L01FA CD20 (CLUSTERS OF DIFFERENTIATION 20) INHIBITORS
L01FB CD22 (CLUSTERS OF DIFFERENTIATION 22) INHIBITORS
L01FC CD38 (CLUSTERS OF DIFFERENTIATION 38) INHIBITORS
L01FD HER2 (HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2) INHIBITORS
L01FE EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR) INHIBITORS
L01FF PD-1/PDL-1 (PROGRAMMED CELL DEATH PROTEIN 1/DEATH LIGAND 1) INHIBITORS
L01FG VEGF/VEGFR (VASCULAR ENDOTHELIAL GROWTH FACTOR) INHIBITORS
L01FX OTHER MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
L01XA PLATINUM COMPOUNDS
L01XB METHYLHYDRAZINES
L01XD SENSITIZERS USED IN PHOTODYNAMIC/RADIATION THERAPY
L01XE PROTEIN KINASE INHIBITORS
L01XF RETINOIDS FOR CANCER TREATMENT
L01XG PROTEASOME INHIBITORS
L01XH HISTONE DEACETYLASE (HDAC) INHIBITORS
L01XJ HEDGEHOG PATHWAY INHIBITORS
L01XK POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS
L01XL Antineoplastic cell and gene therapy
L01XX OTHER ANTINEOPLASTIC AGENTS
L02AA ESTROGENS
L02AB PROGESTOGENS
L02AE GONADOTROPIN RELEASING HORMONE ANALOGUES
L02BA ANTI-ESTROGENS
L02BB ANTI-ANDROGENS
L02BG ENZYME INHIBITORS
L02BX OTHER HORMONE ANTAGONISTS AND RELATED AGENTS
L03AA COLONY STIMULATING FACTORS
L03AB INTERFERONS
L03AC INTERLEUKINS
L03AX OTHER IMMUNOSTIMULANTS
L04AA SELECTIVE IMMUNOSUPPRESSANTS
L04AB TUMOR NECROSIS FACTOR ALPHA (TNF-?) INHIBITORS
L04AC INTERLEUKIN INHIBITORS
L04AD CALCINEURIN INHIBITORS
L04AX OTHER IMMUNOSUPPRESSANTS
M01AA BUTYLPYRAZOLIDINES
M01AB ACETIC ACID DERIVATIVES AND RELATED SUBSTANCES
M01AC OXICAMS
M01AE PROPIONIC ACID DERIVATIVES
M01AG FENAMATES
M01AH COXIBS
M01AX OTHER ANTIINFLAMMATORY AND ANTIRHEUMATIC AGENTS, NON-STEROIDS
M01CB GOLD PREPARATIONS
M01CC PENICILLAMINE AND SIMILAR AGENTS
M02AA ANTIINFLAMMATORY PREPARATIONS, NON-STEROIDS FOR TOPICAL USE
M02AB CAPSAICIN AND SIMILAR AGENTS
M02AC PREPARATIONS WITH SALICYLIC ACID DERIVATIVES
M02AX OTHER TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M03AB CHOLINE DERIVATIVES
M03AC OTHER QUATERNARY AMMONIUM COMPOUNDS
M03AX OTHER MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
M03BA CARBAMIC ACID ESTERS
M03BB OXAZOL, THIAZINE, AND TRIAZINE DERIVATIVES
M03BC ETHERS, CHEMICALLY CLOSE TO ANTIHISTAMINES
M03BX OTHER CENTRALLY ACTING AGENTS
M03CA DANTROLENE AND DERIVATIVES
M04AA PREPARATIONS INHIBITING URIC ACID PRODUCTION
M04AB PREPARATIONS INCREASING URIC ACID EXCRETION
M04AC PREPARATIONS WITH NO EFFECT ON URIC ACID METABOLISM
M05BA BISPHOSPHONATES
M05BB BISPHOSPHONATES, COMBINATIONS
M05BC BONE MORPHOGENETIC PROTEINS
M05BX OTHER DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
M09AB ENZYMES
M09AX OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
N01AB HALOGENATED HYDROCARBONS
N01AF BARBITURATES, PLAIN
N01AH OPIOID ANESTHETICS
N01AX OTHER GENERAL ANESTHETICS
N01BA ESTERS OF AMINOBENZOIC ACID
N01BB AMIDES
N01BX OTHER LOCAL ANESTHETICS
N02AA NATURAL OPIUM ALKALOIDS
N02AB PHENYLPIPERIDINE DERIVATIVES
N02AC DIPHENYLPROPYLAMINE DERIVATIVES
N02AD BENZOMORPHAN DERIVATIVES
N02AE ORIPAVINE DERIVATIVES
N02AJ OPIOIDS IN COMBINATION WITH NON-OPIOID ANALGESICS
N02AX OTHER OPIOIDS
N02BA SALICYLIC ACID AND DERIVATIVES
N02BB PYRAZOLONES
N02BE ANILIDES
N02BG OTHER ANALGESICS AND ANTIPYRETICS
N02CA ERGOT ALKALOIDS
N02CC SELECTIVE SEROTONIN (5HT1) AGONISTS
N02CD CALCITONIN GENE-RELATED PEPTIDE (CGRP) ANTAGONISTS
N02CX OTHER ANTIMIGRAINE PREPARATIONS
N03AA BARBITURATES AND DERIVATIVES
N03AB HYDANTOIN DERIVATIVES
N03AD SUCCINIMIDE DERIVATIVES
N03AE BENZODIAZEPINE DERIVATIVES
N03AF CARBOXAMIDE DERIVATIVES
N03AG FATTY ACID DERIVATIVES
N03AX OTHER ANTIEPILEPTICS
N04AA TERTIARY AMINES
N04AB ETHERS CHEMICALLY CLOSE TO ANTIHISTAMINES
N04AC ETHERS OF TROPINE OR TROPINE DERIVATIVES
N04BA DOPA AND DOPA DERIVATIVES
N04BB ADAMANTANE DERIVATIVES
N04BC DOPAMINE AGONISTS
N04BD MONOAMINE OXIDASE B INHIBITORS
N04BX OTHER DOPAMINERGIC AGENTS
N05AA PHENOTHIAZINES WITH ALIPHATIC SIDE-CHAIN
N05AB PHENOTHIAZINES WITH PIPERAZINE STRUCTURE
N05AC PHENOTHIAZINES WITH PIPERIDINE STRUCTURE
N05AD BUTYROPHENONE DERIVATIVES
N05AE INDOLE DERIVATIVES
N05AF THIOXANTHENE DERIVATIVES
N05AG DIPHENYLBUTYLPIPERIDINE DERIVATIVES
N05AH DIAZEPINES, OXAZEPINES, THIAZEPINES AND OXEPINES
N05AL BENZAMIDES
N05AN LITHIUM
N05AX OTHER ANTIPSYCHOTICS
N05BA BENZODIAZEPINE DERIVATIVES
N05BB DIPHENYLMETHANE DERIVATIVES
N05BC CARBAMATES
N05BE AZASPIRODECANEDIONE DERIVATIVES
N05BX OTHER ANXIOLYTICS
N05CB BARBITURATES, COMBINATIONS
N05CD BENZODIAZEPINE DERIVATIVES
N05CF BENZODIAZEPINE RELATED DRUGS
N05CH MELATONIN RECEPTOR AGONISTS
N05CM OTHER HYPNOTICS AND SEDATIVES
N05CX HYPNOTICS AND SEDATIVES IN COMBINATION, EXCL. BARBITURATES
N06AA NON-SELECTIVE MONOAMINE REUPTAKE INHIBITORS
N06AB SELECTIVE SEROTONIN REUPTAKE INHIBITORS
N06AF MONOAMINE OXIDASE INHIBITORS, NON-SELECTIVE
N06AG MONOAMINE OXIDASE A INHIBITORS
N06AX OTHER ANTIDEPRESSANTS
N06BA CENTRALLY ACTING SYMPATHOMIMETICS
N06BC XANTHINE DERIVATIVES
N06BX OTHER PSYCHOSTIMULANTS AND NOOTROPICS
N06CA ANTIDEPRESSANTS IN COMBINATION WITH PSYCHOLEPTICS
N06DA ANTICHOLINESTERASES
N06DX OTHER ANTI-DEMENTIA DRUGS
N07AA ANTICHOLINESTERASES
N07AB CHOLINE ESTERS
N07AX OTHER PARASYMPATHOMIMETICS
N07BA DRUGS USED IN NICOTINE DEPENDENCE
N07BB DRUGS USED IN ALCOHOL DEPENDENCE
N07BC DRUGS USED IN OPIOID DEPENDENCE
N07CA ANTIVERTIGO PREPARATIONS
N07XX OTHER NERVOUS SYSTEM DRUGS
P01AB NITROIMIDAZOLE DERIVATIVES
P01AX OTHER AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES
P01BA AMINOQUINOLINES
P01BB BIGUANIDES
P01BC METHANOLQUINOLINES
P01BD DIAMINOPYRIMIDINES
P01BE ARTEMISININ AND DERIVATIVES
P01BF ARTEMISININ AND DERIVATIVES, COMBINATIONS
P01BX OTHER ANTIMALARIALS
P01CX OTHER AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS
P02CA BENZIMIDAZOLE DERIVATIVES
P02CE IMIDAZOTHIAZOLE DERIVATIVES
P02CF AVERMECTINES
P02DA SALICYLIC ACID DERIVATIVES
P03AB CHLORINE CONTAINING PRODUCTS
P03AC PYRETHRINES, INCL. SYNTHETIC COMPOUNDS
P03AX OTHER ECTOPARASITICIDES, INCL. SCABICIDES
R01AA SYMPATHOMIMETICS, PLAIN
R01AB SYMPATHOMIMETICS, COMBINATIONS EXCL. CORTICOSTEROIDS
R01AC ANTIALLERGIC AGENTS, EXCL. CORTICOSTEROIDS
R01AD CORTICOSTEROIDS
R01AX OTHER NASAL PREPARATIONS
R01BA SYMPATHOMIMETICS
R02AA ANTISEPTICS
R02AB ANTIBIOTICS
R02AX OTHER THROAT PREPARATIONS
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03AB NON-SELECTIVE BETA-ADRENORECEPTOR AGONISTS
R03AC SELECTIVE BETA-2-ADRENORECEPTOR AGONISTS
R03AK ADRENERGICS AND OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03AL ADRENERGICS IN COMBINATION WITH ANTICHOLINERGICS
R03BA GLUCOCORTICOIDS
R03BB ANTICHOLINERGICS
R03BC ANTIALLERGIC AGENTS, EXCL. CORTICOSTEROIDS
R03CA ALPHA- AND BETA-ADRENORECEPTOR AGONISTS
R03CC SELECTIVE BETA-2-ADRENORECEPTOR AGONISTS
R03DA XANTHINES
R03DC LEUKOTRIENE RECEPTOR ANTAGONISTS
R03DX OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R05 COUGH AND COLD PREPARATIONS
R05CA EXPECTORANTS
R05CB MUCOLYTICS
R05DA OPIUM ALKALOIDS AND DERIVATIVES
R05DB OTHER COUGH SUPPRESSANTS
R05FA OPIUM DERIVATIVES AND EXPECTORANTS
R05FB OTHER COUGH SUPPRESSANTS AND EXPECTORANTS
R05X OTHER COLD COMBINATION PREPARATIONS
R06AA AMINOALKYL ETHERS
R06AB SUBSTITUTED ALKYLAMINES
R06AD PHENOTHIAZINE DERIVATIVES
R06AE PIPERAZINE DERIVATIVES
R06AX OTHER ANTIHISTAMINES FOR SYSTEMIC USE
R07AA LUNG SURFACTANTS
R07AB RESPIRATORY STIMULANTS
R07AX OTHER RESPIRATORY SYSTEM PRODUCTS
S SENSORY ORGANS
S01AA ANTIBIOTICS
S01AB SULFONAMIDES
S01AD ANTIVIRALS
S01AE FLUOROQUINOLONES
S01AX OTHER ANTIINFECTIVES
S01BA CORTICOSTEROIDS, PLAIN
S01BC ANTIINFLAMMATORY AGENTS, NON-STEROIDS
S01CA CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION
S01CB CORTICOSTEROIDS/ANTIINFECTIVES/MYDRIATICS IN COMBINATION
S01CC ANTIINFLAMMATORY AGENTS, NON-STEROIDS AND ANTIINFECTIVES IN COMBINATION
S01EA SYMPATHOMIMETICS IN GLAUCOMA THERAPY
S01EB PARASYMPATHOMIMETICS
S01EC CARBONIC ANHYDRASE INHIBITORS
S01ED BETA BLOCKING AGENTS
S01EE PROSTAGLANDIN ANALOGUES
S01EX OTHER ANTIGLAUCOMA PREPARATIONS
S01FA ANTICHOLINERGICS
S01FB SYMPATHOMIMETICS EXCL. ANTIGLAUCOMA PREPARATIONS
S01GA SYMPATHOMIMETICS USED AS DECONGESTANTS
S01GX OTHER ANTIALLERGICS
S01HA LOCAL ANESTHETICS
S01JA COLOURING AGENTS
S01KA VISCOELASTIC SUBSTANCES
S01LA ANTINEOVASCULARISATION AGENTS
S01XA OTHER OPHTHALMOLOGICALS
S02AA ANTIINFECTIVES
S02BA CORTICOSTEROIDS
S02CA CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION
S02DA ANALGESICS AND ANESTHETICS
S02DC INDIFFERENT PREPARATIONS
S03AA ANTIINFECTIVES
S03BA CORTICOSTEROIDS
S03CA CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION
V01AA ALLERGEN EXTRACTS
V03AA DRUGS FOR TREATMENT OF CHRONIC ALCOHOLISM
V03AB ANTIDOTES
V03AC IRON CHELATING AGENTS
V03AE DRUGS FOR TREATMENT OF HYPERKALEMIA AND HYPERPHOSPHATEMIA
V03AF DETOXIFYING AGENTS FOR ANTINEOPLASTIC TREATMENT
V03AG DRUGS FOR TREATMENT OF HYPERCALCEMIA
V03AH DRUGS FOR TREATMENT OF HYPOGLYCEMIA
V03AK TISSUE ADHESIVES
V03AN MEDICAL GASES
V03AX OTHER THERAPEUTIC PRODUCTS
V04CA TESTS FOR DIABETES
V04CC TESTS FOR BILE DUCT PATENCY
V04CD TESTS FOR PITUITARY FUNCTION
V04CF TUBERCULOSIS DIAGNOSTICS
V04CG TESTS FOR GASTRIC SECRETION
V04CH TESTS FOR RENAL FUNCTION
V04CJ TESTS FOR THYREOIDEA FUNCTION
V04CL TESTS FOR ALLERGIC DISEASES
V04CM TESTS FOR FERTILITY DISTURBANCES
V04CX OTHER DIAGNOSTIC AGENTS
V06 GENERAL NUTRIENTS
V06CA NUTRIENTS WITHOUT PHENYLALANINE
V06D OTHER NUTRIENTS
V06DB FAT/CARBOHYDRATES/PROTEINS/MINERALS/VITAMINS, COMBINATIONS
V06DC CARBOHYDRATES
V06DD AMINO ACIDS, INCL. COMBINATIONS WITH POLYPEPTIDES
V06DE AMINO ACIDS/CARBOHYDRATES/MINERALS/VITAMINS, COMBINATIONS
V06DF MILK SUBSTITUTES
V06DX OTHER COMBINATIONS OF NUTRIENTS
V07AB SOLVENTS AND DILUTING AGENTS, INCL. IRRIGATING SOLUTIONS
V07AX WASHING AGENTS ETC.
V07AY OTHER NON-THERAPEUTIC AUXILIARY PRODUCTS
V08AA WATERSOLUBLE, NEPHROTROPIC, HIGH OSMOLAR X-RAY CONTRAST MEDIA
V08AB WATERSOLUBLE, NEPHROTROPIC, LOW OSMOLAR X-RAY CONTRAST MEDIA
V08AC WATERSOLUBLE, HEPATOTROPIC X-RAY CONTRAST MEDIA
V08AD NON-WATERSOLUBLE X-RAY CONTRAST MEDIA
V08BA BARIUM SULFATE CONTAINING X-RAY CONTRAST MEDIA
V08CA PARAMAGNETIC CONTRAST MEDIA
V08CB SUPERPARAMAGNETIC CONTRAST MEDIA
V08DA ULTRASOUND CONTRAST MEDIA
V09AB IODINE (123I) COMPOUNDS
V09CA TECHNETIUM (99m Tc) COMPOUNDS
V09IB INDIUM (111IN) COMPOUNDS
V09IX OTHER DIAGNOSTIC RADIOPHARMACEUTICALS FOR TUMOUR DETECTION
V10XA IODINE (131I) COMPOUNDS
V10XX VARIOUS THERAPEUTIC RADIOPHARMACEUTICALS

The labels on a blue background are the medicines that exist under the status "low cost".
The codes mentioned above can be used in rates and expenses, or only in expenses. We invite you to consult the full report for more information.

Click below to see the graph illustrating the evolution of the breakdown by volume of ATC codes used for the rates.

Polymedication (65 ans et plus) (2022)

Older than or equal to 65 years

Min 81 ddd per drug per year & min 5 drugs per patient per year

2022

  • ATC codesATC codes
  • Age Sex CVAge, sex and CV
  • Rates by sexRates by sex
  • Reimbursement rateReimbursement rate
  • TrendsTrends by region
  • Trends breakTrends break
  • Dot PlotDot Plot
  • Funnel PlotFunnel plot
  • Provincial consumptionDDD per patient by province
  • DDD patientQuantity per patient
  • MapDistribution map
  • Low-costLow-cost DDD


WE ARE INTERESTED IN YOUR OPINION

Do you have any experience in this area ? We listen to you !

Send us an email

   Download the full report
 Download the methodology